Three continuous lymphoblastoid cell lines, 2 productive of nucleocapsids and 1 nonproductive line, were studied for their content of Epstein-Barr viral (EBV) antigens during transition from stationary to logarithmic phase growth. As a preliminary step, viable cells were separated from degenerating ones in discontinuous gradients of serum albumin. Viral capsid antigens were found in both living and dead cells of the 2 producer lines; however, complement fixing (CF) antigens and nuclear antigen were detected only in viable cell subpopulations. In contrast, the proportion of cells with viral capsid antigen in the producer lines increased 7-to 24-fold following entry of resting populations into the phase of exponential growth.
problem was perhaps first appreciated by Noyes and Mellors who found that in Shope papilloma of the cottontail rabbit viral antigens were present in the nondividing differentiated keratinized layers of the tumor, although such antigens were not detectable in the rapidly proliferating deeper epithelial cells (1) . They postulated that the proliferating cells contained viral nucleic acids but did not produce viral specific proteins.
The present experiments were undertaken to determine whether the phase of cellular proliferation studied in vitro affected the expression of Epstein-Barr virus (EBV) antigens. This system was of particular interest for two reasons: first, spontaneous activation of the EBV genome leading to formation of nucleocapsids occurs in only a small fraction of the population of certain productive cell lines, although cloning experiments indicate that all cells in these lines contain at least one complete copy of the viral genome (2-4). It is not known whether physiologic events leading to the spontaneous initiation of synthesis of EBV particles in a few cells occur in log phase, stationary phase, or during cell death. Second, cells transformed by EBV are of lymphoid origin and there is now considerable evidence relating viral replication to active growth of lymphoid cells. For example, replication of several viruses is enhanced in primary cultures of lymphocytes activated by phytohemagglutinin (5) (6) (7) . Specific antigen stimulation of lymphocytes may also result in enhanced virus growth. This is apparently the case for dengue virus which replicates to a greater extent in cultured lymphocytes from immune primates than from nonimmune monkeys, presumably because of the blastogenic properties of the infecting virus (8) . Furthermore, experimental graft versus host disease in mice with its attendant lymphoproliferation leads to replication of RNA tumor viruses (9, 10) . Thus events affecting lymphocyte growth in vivo may affect expression of an endogenous viral genome.
METHODS

Cells and Media
Three lymphoblastoid cell lines, 2 productive and 1 nonproductive of nucleocapsids were examined. From the P3J-HR1 clone of Burkitt lymphoma cells single cell subclones were derived in antiserum to EBV ( 1 1 ). One clone (No. 8) in which the level of viral capsid antigen was 1-4% of randomly growing cells was used. The B95-8 line was derived following exposure of cotton-top marmoset peripheral blood leukocytes to an EBV strain from an infectious mononucleosis patient (12) . Raji, originally from a Burkitt lymphoma patient, produced neither viral capsid antigens nor nucleocapsids, but the EBV genome, detectable by methods of nucleic acid hybridization, is associated with Raji chromosomes (13a, 13b) . Media for all experiments was RPMI 1640 (Grand Island Biological Co.) plus 10% heated (560C for %2 hr) fetal bovine serum, penicillin (50 /Ag/ml), streptomycin (50 ,ug/ml), and amphotericin B (1.0 mg/ml). Stock cultures of each line were maintained by weekly two to one splits.
Cell Growth Curves and Separation of Cellular Populations
Cells of the 3 lines used in the present experiments were manipulated in a manner previously described for derivation of cultures in stationary phase (14) . This consisted of inoculation of cells at low density and subsequent omission of fresh medium. Cell growth was initiated following addition of 2 parts of fresh complete (16) . Cells were enumerated per slide. Complement fixing antigens were prepared from cell extracts (17) . Cells were washed twice and resuspended in veronal buffered saline pH 7.2 with 0.1 % bovine serum albumin at a concenitration of 5 X 107/ml. Cells were lysed by 3 cycles of alternate freezing and thawing and debris removed by centrifugation at 800 g for 10 min. The supernatant fluids were used as antigen in microtiter complement fixation tests employing 1.3 50% hemolytic units of complement. The anticomplement immunofluorescence technique of Reedman and Klein was used to study EB nuclear antigens (EBNA) in acetone fixed preparations (18) . An indirect test with fluorescein conjugated rabbit antihuman B lc globulin (Hyland Laboratories) was performed. Cell spreads were washed with Hank's balanced salt solution pH 6.9. Antisera to EBV used in this test contained as a source of complement 10% (vol/vol) fresh human serum, lacking EBV antibodies.
A ntisera
All 3 antigens (viral capsid, complement fixing, and EBNA) were studied with the same pair of human reference sera. The antibody positive serum (RM) was from a healthy adult with a history of mononucleosis 20 years ago. The antibody negative control serum (LH) used in each test also was from a healthy adult. The sera were used at a 1 :10 dilution to study viral capsid antigens and the intranuclear antigen and at a 1:4 dilution to measure complement fixing antigens. In selected experiments viral capsid antigens were also determined with 1: 10 dilution of pooled positive (titer 1:80) postinoculation cotton-top marmoset sera; pooled antibody negative preinfection marmoset sera served as a control (19 (Figs. 3, 5) . The level of capsid antigen increased as the cells entered exponential growth to 2.4% for Clone 8 and 13% for B95-8. In the experimeiit illustrated for Clone 8 (Fig. 3) there was a lag of 3 days before cell doubling began; during this time viral capsid antigen was at a barely detectable level, and only rose concomitant with exponential growth. No These findings indicated differences in the cellular content of the viral capsid and complement fixing antigens, but since the 2 antigens were measured by different techniques the results could not be strictly compared. The development by Reedman and Klein of an anticomplement immunofluorescence test for EBV-related intranuclear antigen permitted assay for both antigens to be carried out on the same set of cell smears by the same method, namely, immunofluorescence. In the 3 cell lines 90-100% of cells contained EBNA during all phases of growth. In producer lines the anticomplement immuncfluorescence test demonstrated 2 types of fluorescent staining: in cells with capsid antigen there was dense fluorescence in both nucleus and cytoplasm, while in all of the remaining cells without capsid antigen the intranuclear antigen was reticular and appeared to be located on chromatin and nuclear membranes (Fig. 6) . Only the latter pattern was identified in the Raji line.
DISCUSSION
Several techniques have permitted the analysis herein reported of the effect of cell growth on the expression of EB viral antigens. It has been relatively easy to manipulate in vii/-o conditions to derive stationary and logarithmic phase cultures. Cells in these two phases of growth can be readily differentiated on the basis of size, morphology, and total DNA synthesis. It was possible to remove degenerating cells from the cultures and thus to eliminate those cells which had already produced nucleocapsids. Finally, a doubly cloned line was studied in one instance to assure that the results reflected different physiologic states of a genetically homogenous population.
The spontaneous activation of viral capsid antigen occurred during and following exponential phase growth when there was a seven to more than twentyfold increase in the number of cells with this antigen. Since capsid antigen did not increase until after cell doubling, both DNA synthesis and mitosis may be necessary to trigger its production. In previous studies of the P,HR1 line (the parent of Clone 8) both Gergley and Hampar found that inhibitors of DNA synthesis, such as cytosine arabinoside and 5' bromodeoxyuridine, depress the level of capsid antigen (21, 22) . Both investigators noted that removal of the drugs led to a burst of capsid antigen synthesis. The phenomenon of stimulation of capsid antigen production following reversal of inhibition of DNA synthesis may be due to synchrony of the cells followed by virus activation in the subsequent cell cycle. In future experiments it will be important to define precisely steps leading to spontaneous activation of the viral genome. In particular it will be essential to define, by use of synchronized cell populations, that phase of the cell's mitotic cycle in which spontaneous expression of EBV specific information is initiated. Our studies do not provide information on the relationship of the cell mitotic cycle to spontaneous induction of EBV; however, Hampar and co-workers have recently indicated that an event in S phase is critical in determining the induction of EBV "early antigen" following application of halogenated pyrimidines to the Raji line (23) . Does (25) . Complement fixing activity in crude cell extracts is apparently due to at least two soluble components, one of which is inactivated by heating at 56°C (26) . As suggested by others, the analogies between the EBV complement fixing antigen complex and the "t" antigen system of the papova viruses are striking (17, 18 (26, 27) ,
